Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	55.45	-120.19	-269.79
Graham Fair Price	-36.66	1989.29	3140.87
PEG	949.08	0.13	0.01
Price/Book	-23.45	0.79	1.03
Price/Cash Flow	64.09	-9.84	-27.41
Prices/Earnings	-76.10	-7.70	-4.37
Price/Sales	-30.89	4.39	6.35
Price/FCF	64.09	-9.84	-27.41
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-50.39	0.04	0.09
Operating Margin	-24.46	-0.13	-0.11
ROA	56.38	-0.02	-0.04
ROE	-0.06	-0.03	56.53
ROIC	< 0.005	-0.02	-58.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.03	-99.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-5.63	-0.32	94.24
EPS QOQ	-3.47	0.58	-83.21
FCF QOQ	-0.40	-1.05	-160.39
Revenue QOQ	-0.11	0.06	-44.27
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.50	49.77	7.03
Days Sales Outstanding (DSO)	45.79	52.24	14.08
Inventory Turnover	1.94	1.81	-6.57
Debt/Capitalization	0.33	0.34	2.76
Quick Ratio	2.39	2.02	-15.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2723.78	2616.56	-3.94
Cash	954.77	529.08	-44.59
Capex	-128.06	-102.16	20.22
Free Cash Flow	-102.69	-210.31	-104.80
Revenue	443.42	471.80	6.40
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.81	2.67	-5.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-50.84	-41.27	18.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating